We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
222 hedge funds and large institutions have $1.22B invested in Corcept Therapeutics in 2018 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 79 increasing their positions, 68 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
62% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 26
16% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 68
7% more funds holding
Funds holding: 207 → 222 (+15)
1.58% more ownership
Funds ownership: 77.22% → 78.8% (+1.6%)
3% less capital invested
Capital invested by funds: $1.26B → $1.22B (-$41M)
38% less call options, than puts
Call options by funds: $6.78M | Put options by funds: $10.9M
Holders
222
Holders Change
+15
Holders Change %
+7.25%
% of All Funds
4.95%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
42
Increased
79
Reduced
68
Closed
26
Calls
$6.78M
Puts
$10.9M
Net Calls
-$4.1M
Net Calls Change
+$1.36M
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$15.5M |
| 2 |
Millennium Management
New York
|
+$8.1M |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$6.04M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$6.03M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.44M |
Top Sellers
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$16.1M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$7.87M |
| 3 |
Capital Fund Management (CFM)
Paris,
France
|
-$7.58M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$6.41M |
| 5 |
Morgan Stanley
New York
|
-$4.87M |
